Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Delivering purposeful solutions at Obesity Week 2025

    October 9, 2025 | Obesity Week 

    We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

    - PMLiVE

    Obesity Week 2025 is the premier global event dedicated to obesity research, prevention, and care – bringing together leading scientists, clinicians, and innovators to advance progress in one of the most dynamic areas of healthcare.​

    At Inizio, we’re uniting science, strategy, and creativity to deliver purposeful solutions across obesity and cardiometabolic health. Our integrated teams collaborate across the full commercialization journey to help clients navigate complexity, unlock value, and enhance outcomes at every stage of development and delivery.​

    Our experience spans the full obesity ecosystem: we’ve supported over 20 leading anti-obesity therapies, partnered on 80% of the largest GLP-1 assets, and worked across 18 specialized services to deliver smarter, connected solutions that make an impact.​

    Visit us at booth #812 to meet our experts and explore how Inizio’s integrated expertise is transforming the future of obesity and cardiometabolic care.​

    If you’d like to meet with us at Obesity Week, please get in touch.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Webcast: AI in MRX: Harnessing the power of AI + people

    Artificial intelligence (AI) in market research has surged in recent years, with a flow of innovative tools and techniques which have the potential to revolutionize the landscape. But to unlock...

    Navigating challenges of MedTech research with rare-disease patients

    Authored by: Tom Donnelly, MedTech Director and Amanda Pirraglia, Associate Director. Published in Quirk's Magazine.

    Product launch: What market research when?

    Get the insights you need, when you need them, for your product launch planning

    Therapy Watch launches new tracker covering Alzheimer’s Disease

    The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.

    Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

    Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

    Healthcare in the age of AI: How will artificial intelligence impact future decision-making?

    Authored by: Constanza Salas, Jhon Galindo and Rachel Howard

    Therapy Watch launches new tracker covering Postpartum Depression

    The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry

    Value-based pricing reform: Strengthening the ‘front door’ to the Colombian pharmaceutical market

    Authored by: Marc Garcia and Tania Rodrigues

    Infographic: Rare Diseases in China

    How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.

    New syndicated COPD report now available

    Living with COPD 2023